You have 9 free searches left this month | for more free features.

City

San Francisco (1)

Stamford (1)

Condition

Adductor Spasmodic Dysphonia (1)

Migraine Disorders (1)

Spasmodic Dysphonia (1)

Voice Disorders (1)

Overall Status

Recruiting (1)

Withdrawn (1)

Sign in for free

Phase

phase 1/phase 2 (1)

Sponsor

Ki Health Partners. LLC (1)

University of California, San Francisco (1)

Collaborator

Revance Therapeutics, Inc. (1)

The Los Angeles Headache Center (1)

Intervention

daxibotulinumtoxina (2)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (1)

Observational (1)

daxibotulinumtoxina

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

DaxibotulinumtoxinA for Migraine Prevention

Recruiting

Migraine Disorders

DaxibotulinumtoxinA

Stamford, Connecticut

New England Institute For Clinical Research

Nov 30, 2023

Adductor Spasmodic Dysphonia, Voice Disorders, Spasmodic Dysphonia Trial in San Francisco (DaxibotulinumtoxinA)

Withdrawn

Adductor Spasmodic Dysphonia
+2 more

DaxibotulinumtoxinA

San Francisco, California

UCSF

Mar 2, 2022